Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Systematic Surgical Assessment of Deceased-Donor Kidneys as a Predictor of Short-Term Transplant Outcomes.

Tierie EL, Roodnat JI, Dor FJMF.

Eur Surg Res. 2019;60(3-4):97-105. doi: 10.1159/000501602. Epub 2019 Sep 3.

2.

Living Donor Kidney Transplantation in a Patient With Epidermolysis Bullosa: A Case Report.

Ceuppens SHE, Kimenai HJAN, Roodnat JI, Mertens Zur Borg IRAM, Duipmans JC, IJzermans JNM, Minnee RC.

Transplant Proc. 2019 Jul 19. pii: S0041-1345(19)30487-7. doi: 10.1016/j.transproceed.2019.04.049. [Epub ahead of print]

PMID:
31331719
3.

Oxalate deposition in renal allograft biopsies within 3 months after transplantation is associated with allograft dysfunction.

Snijders MLH, Hesselink DA, Clahsen-van Groningen MC, Roodnat JI.

PLoS One. 2019 Apr 16;14(4):e0214940. doi: 10.1371/journal.pone.0214940. eCollection 2019.

4.

Impact of Aortoiliac Stenosis on Graft and Patient Survival in Kidney Transplant Recipients Using the TASC II Classification.

Rijkse E, Kimenai HJAN, Roodnat JI, Ten Raa S, Bijdevaate DC, van Dam JL, Muller K, IJzermans JNM, van der Zijden MA, Minnee RC.

Transplantation. 2019 Oct;103(10):2164-2172. doi: 10.1097/TP.0000000000002635.

PMID:
30801546
5.

The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy.

van der Zwan M, Clahsen-Van Groningen MC, Roodnat JI, Bouvy AP, Slachmuylders CL, Weimar W, Baan CC, Hesselink DA, Kho MML.

Ann Transplant. 2018 Aug 17;23:577-590. doi: 10.12659/AOT.909646.

6.

Antegrade Balloon Dilatation as a Treatment Option for Posttransplant Ureteral Strictures: Case Series of 50 Patients.

Ooms LSS, Moelker A, Roodnat JI, Ijzermans JNM, Idu MM, Terkivatan T.

Exp Clin Transplant. 2018 Apr;16(2):150-155.

7.

A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.

Roodnat JI, de Mik-van Egmond AME, Visser WJ, Berger SP, van der Meijden WAG, Knauf F, van Agteren M, Betjes MGH, Hoorn EJ.

Transplant Direct. 2017 Nov 8;3(12):e331. doi: 10.1097/TXD.0000000000000748. eCollection 2017 Dec.

8.

DCD donor hemodynamics as predictor of outcome after kidney transplantation.

Peters-Sengers H, Houtzager JHE, Heemskerk MBA, Idu MM, Minnee RC, Klaasen RW, Joor SE, Hagenaars JAM, Rebers PM, van der Heide JJH, Roodnat JI, Bemelman FJ.

Am J Transplant. 2018 Aug;18(8):1966-1976. doi: 10.1111/ajt.14676. Epub 2018 Mar 13.

9.

Kidney transplantation in patients declined by other centres.

Glijn NH, Roodnat JI, Dor FJ, Betjes MG, Zuidema WC, Weimar W, Berger SP.

Neth J Med. 2017 Mar;75(2):74-80.

10.

A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation.

Shuker N, Shuker L, van Rosmalen J, Roodnat JI, Borra LC, Weimar W, Hesselink DA, van Gelder T.

Transpl Int. 2016 Nov;29(11):1158-1167. doi: 10.1111/tri.12798. Epub 2016 Jun 28.

11.

Increased risk of graft failure and mortality in Dutch recipients receiving an expanded criteria donor kidney transplant.

van Ittersum FJ, Hemke AC, Dekker FW, Hilbrands LB, Christiaans MH, Roodnat JI, Hoitsma AJ, van Diepen M.

Transpl Int. 2017 Jan;30(1):14-28. doi: 10.1111/tri.12863.

12.

An Acute Cellular Rejection With Detrimental Outcome Occurring Under Belatacept-Based Immunosuppressive Therapy: An Immunological Analysis.

de Graav GN, Hesselink DA, Dieterich M, Kraaijeveld R, Douben H, de Klein A, Roelen DL, Weimar W, Roodnat JI, Clahsen-van Groningen MC, Baan CC.

Transplantation. 2016 May;100(5):1111-9. doi: 10.1097/TP.0000000000001004.

PMID:
26599491
13.

A High Comorbidity Score Should Not be a Contraindication for Kidney Transplantation.

Laging M, Kal-van Gestel JA, van de Wetering J, IJzermans JN, Betjes MG, Weimar W, Roodnat JI.

Transplantation. 2016 Feb;100(2):400-6. doi: 10.1097/TP.0000000000000973.

PMID:
26516673
14.

Alternative Living Kidney Donation Programs Boost Genetically Unrelated Donation.

Poldervaart RA, Laging M, Royaards T, Kal-van Gestel JA, van Agteren M, de Klerk M, Zuidema W, Betjes MG, Roodnat JI.

J Transplant. 2015;2015:748102. doi: 10.1155/2015/748102. Epub 2015 Sep 2.

15.

Kidney retransplantation in the ipsilateral iliac fossa: a surgical challenge.

Ooms LS, Roodnat JI, Dor FJ, Tran TC, Kimenai HJ, Ijzermans JN, Terkivatan T.

Am J Transplant. 2015 Nov;15(11):2947-54. doi: 10.1111/ajt.13369. Epub 2015 Jul 7.

16.

Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.

Shuker N, Cadogan M, van Gelder T, Roodnat JI, Kho MM, Weimar W, Hesselink DA.

Ther Drug Monit. 2015 Apr;37(2):262-9. doi: 10.1097/FTD.0000000000000136.

PMID:
25265255
17.

Understanding the influence of ethnicity and socioeconomic factors on graft and patient survival after kidney transplantation.

Laging M, Kal-van Gestel JA, van de Wetering J, IJzermans JN, Weimar W, Roodnat JI.

Transplantation. 2014 Nov 15;98(9):974-8. doi: 10.1097/TP.0000000000000164.

PMID:
24926831
18.

Independent risk factors for urological complications after deceased donor kidney transplantation.

Slagt IK, Ijzermans JN, Visser LJ, Weimar W, Roodnat JI, Terkivatan T.

PLoS One. 2014 Mar 7;9(3):e91211. doi: 10.1371/journal.pone.0091211. eCollection 2014.

19.

15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation.

Roodnat JI, Hilbrands LB, Hené RJ, de Sévaux RG, Smak Gregoor PJ, Kal-van Gestel JA, Konijn C, van Zuilen A, van Gelder T, Hoitsma AJ, Weimar W.

Transplantation. 2014 Jul 15;98(1):47-53. doi: 10.1097/01.TP.0000442774.46133.71.

PMID:
24521775
20.

Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.

Laging M, Kal-van Gestel JA, Haasnoot GW, Claas FH, van de Wetering J, Ijzermans JN, Weimar W, Roodnat JI.

Transplantation. 2014 Feb 15;97(3):330-6. doi: 10.1097/01.TP.0000435703.61642.43.

PMID:
24202143
21.

Genetic variants of FOXP3 influence graft survival in kidney transplant patients.

Engela AU, Boer K, Roodnat JI, Peeters AM, Eilers PH, Kal-van Gestel JA, Rivadeneira F, Weimar W, Baan CC.

Hum Immunol. 2013 Jun;74(6):751-7. doi: 10.1016/j.humimm.2013.02.008. Epub 2013 Feb 28.

PMID:
23459079
22.

Long-term outcome of kidney transplantation in patients with a urinary conduit: a case-control study.

Slagt IK, Ijzermans JN, Alamyar M, Verhagen PC, Weimar W, Roodnat JI, Terkivatan T.

Int Urol Nephrol. 2013 Apr;45(2):405-11. doi: 10.1007/s11255-013-0395-1. Epub 2013 Feb 14.

PMID:
23408323
23.

Living donor kidney transplantation among ethnic minorities in the Netherlands: a model for breaking the hurdles.

Ismail SY, Claassens L, Luchtenburg AE, Roodnat JI, Zuidema WC, Weimar W, Busschbach JJ, Massey EK.

Patient Educ Couns. 2013 Jan;90(1):118-24. doi: 10.1016/j.pec.2012.08.004. Epub 2012 Aug 30.

PMID:
22940372
24.

The functional polymorphism Ala258Ser in the innate receptor gene ficolin-2 in the donor predicts improved renal transplant outcome.

Eikmans M, de Canck I, van der Pol P, Baan CC, Haasnoot GW, Mallat MJ, Vergunst M, de Meester E, Roodnat JI, Anholts JD, van Thielen M, Doxiadis II, de Fijter JW, van der Linden PJ, van Beelen E, van Kooten C, Kal-van Gestel JA, Peeters AM, Weimar W, Roelen DL, Rossau R, Claas FH.

Transplantation. 2012 Sep 15;94(5):478-85.

PMID:
22892990
25.

The relative importance of donor age in deceased and living donor kidney transplantation.

Laging M, Kal-van Gestel JA, van de Wetering J, Ijzermans JN, Weimar W, Roodnat JI.

Transpl Int. 2012 Nov;25(11):1150-7. doi: 10.1111/j.1432-2277.2012.01539.x. Epub 2012 Jul 31.

26.

Persistently low transplantation rate of ABO blood type O and highly sensitised patients despite alternative transplantation programs.

Roodnat JI, van de Wetering J, Claas FH, Ijzermans J, Weimar W.

Transpl Int. 2012 Sep;25(9):987-93. doi: 10.1111/j.1432-2277.2012.01526.x. Epub 2012 Jul 9.

27.

Accumulation of unfavorable clinical and socioeconomic factors precludes living donor kidney transplantation.

Roodnat JI, Laging M, Massey EK, Kho M, Kal-van Gestel JA, Ijzermans JN, van de Wetering J, Weimar W.

Transplantation. 2012 Mar 15;93(5):518-23. doi: 10.1097/TP.0b013e318243030f.

PMID:
22298031
28.

KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation.

van Bergen J, Thompson A, Haasnoot GW, Roodnat JI, de Fijter JW, Claas FH, Koning F, Doxiadis II.

Am J Transplant. 2011 Sep;11(9):1959-64. doi: 10.1111/j.1600-6143.2011.03621.x. Epub 2011 Jun 30.

29.

Use of stenting in living donor kidney transplantation: does it reduce vesicoureteral complications?

Dols LF, Terkivatan T, Kok NF, Tran TC, Weimar W, IJzermans JN, Roodnat JI.

Transplant Proc. 2011 Jun;43(5):1623-6. doi: 10.1016/j.transproceed.2011.01.186.

PMID:
21693245
30.

CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearance.

Pashaee N, Bouamar R, Hesselink DA, Roodnat JI, van Schaik RH, Weimar W, van Gelder T.

Ther Drug Monit. 2011 Jun;33(3):369-71. doi: 10.1097/FTD.0b013e31821a7aa3.

PMID:
21566507
31.

Living kidney donors: impact of age on long-term safety.

Dols LF, Kok NF, Roodnat JI, Tran TC, Terkivatan T, Zuidema WC, Weimar W, Ijzermans JN.

Am J Transplant. 2011 Apr;11(4):737-42. doi: 10.1111/j.1600-6143.2011.03465.x.

32.

Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up.

Hoogeveen EK, Aalten J, Rothman KJ, Roodnat JI, Mallat MJ, Borm G, Weimar W, Hoitsma AJ, de Fijter JW.

Transplantation. 2011 Apr 27;91(8):869-74. doi: 10.1097/TP.0b013e3182100f3a.

PMID:
21326138
33.

A case of primary aldosteronism revealed after renal transplantation.

Hoorn EJ, Hesselink DA, Kho MM, Roodnat JI, Weimar W, van Saase JL, van den Meiracker AH, Zietse R.

Nat Rev Nephrol. 2011 Jan;7(1):55-60. doi: 10.1038/nrneph.2010.158. Epub 2010 Nov 23. Review.

PMID:
21102541
34.

Patient survival after the diagnosis of cancer in renal transplant recipients: a nested case-control study.

van de Wetering J, Roodnat JI, Hemke AC, Hoitsma AJ, Weimar W.

Transplantation. 2010 Dec 27;90(12):1542-6. doi: 10.1097/TP.0b013e3181ff1458.

PMID:
21076383
35.

Ethnically diverse populations and their participation in living kidney donation programs.

Roodnat JI, van de Wetering J, Zuidema W, van Noord MA, Kal-van Gestel JA, Ijzermans JN, Weimar W.

Transplantation. 2010 May 27;89(10):1263-9. doi: 10.1097/TP.0b013e3181d84ca7.

PMID:
20335830
36.

Altruistic donor triggered domino-paired kidney donation for unsuccessful couples from the kidney-exchange program.

Roodnat JI, Zuidema W, van de Wetering J, de Klerk M, Erdman RA, Massey EK, Hilhorst MT, Ijzermans JN, Weimar W.

Am J Transplant. 2010 Apr;10(4):821-7. doi: 10.1111/j.1600-6143.2010.03034.x. Epub 2010 Feb 25.

37.

High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.

Borra LC, Roodnat JI, Kal JA, Mathot RA, Weimar W, van Gelder T.

Nephrol Dial Transplant. 2010 Aug;25(8):2757-63. doi: 10.1093/ndt/gfq096. Epub 2010 Feb 26.

PMID:
20190242
38.

Successful expansion of the living donor pool by alternative living donation programs.

Roodnat JI, Kal-van Gestel JA, Zuidema W, van Noord MA, van de Wetering J, IJzermans JN, Weimar W.

Am J Transplant. 2009 Sep;9(9):2150-6. doi: 10.1111/j.1600-6143.2009.02745.x. Epub 2009 Jul 16.

39.

[Program for good samaritan kidney donation in Erasmus MC, 2000-September 2008].

Zuidema W, Roodnat JI, Kranenburg LW, Erdman RA, Hilhorst MT, IJzermans JN, Weimar W.

Ned Tijdschr Geneeskd. 2009 Mar 28;153(13):595-9. Dutch. No abstract available.

PMID:
19408535
40.

Resolution of IgM nephropathy after rituximab treatment.

Betjes MG, Roodnat JI.

Am J Kidney Dis. 2009 Jun;53(6):1059-62. doi: 10.1053/j.ajkd.2008.10.038. Epub 2008 Dec 11.

PMID:
19084309
41.

Quiz page. Muckle Wells syndrome.

Roodnat JI, de Theije-Kors E, Weening JJ, Weimar W, van Daele PL.

Am J Kidney Dis. 2008 Nov;52(5):A47-9. doi: 10.1053/j.ajkd.2008.07.005. No abstract available.

PMID:
18971008
42.

Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death.

Aalten J, Hoogeveen EK, Roodnat JI, Weimar W, Borm GF, de Fijter JW, Hoitsma AJ.

Transpl Int. 2008 Oct;21(10):985-91. doi: 10.1111/j.1432-2277.2008.00717.x. Epub 2008 Jun 28.

43.

The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation.

van de Wetering J, Weimar CH, Balk AH, Roodnat JI, Holweg CT, Baan CC, van Domburg RT, Weimar W.

Transplantation. 2006 Dec 27;82(12):1744-8.

PMID:
17198270
44.

High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation.

Roodnat JI, van Gurp EA, Mulder PG, van Gelder T, de Rijke YB, de Herder WW, Kal-van Gestel JA, Pols HA, Ijzermans JN, Weimar W.

Transplantation. 2006 Aug 15;82(3):362-7.

PMID:
16906034
45.

The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation.

Lemos FB, Mol WM, Roodnat JI, Uitterlinden A, Ijzermans JN, Weimar W, Baan CC.

Transplantation. 2005 May 15;79(9):1221-5.

PMID:
15880074
46.

Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile.

Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Moons P, Borm G, Hilbrands LB.

Am J Transplant. 2004 Jun;4(6):937-45.

47.

The Cox proportional hazards analysis in words: examples in the renal transplantation field.

Roodnat JI, Mulder PG, Tielens ET, van Riemsdijk IC, van Gelder T, Weimar W.

Transplantation. 2004 Feb 27;77(4):483-8.

PMID:
15084921
48.

The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis.

Roodnat JI, van Riemsdijk IC, Mulder PG, Doxiadis I, Claas FH, IJzermans JN, van Gelder T, Weimar W.

Transplantation. 2003 Jun 27;75(12):2014-8.

PMID:
12829903
49.

Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.

Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Blom HJ, Sweep FC, Demacker PN, Hilbrands LB.

J Am Soc Nephrol. 2003 Jul;14(7):1880-8.

50.

[Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results].

van Gelder T, Hesselink DA, Roodnat JI, Ijzermans JN, Weimar W.

Ned Tijdschr Geneeskd. 2003 May 17;147(20):955-9. Review. Dutch.

PMID:
12784528

Supplemental Content

Loading ...
Support Center